Paper · 2026 · Open access
Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation
Zenodo (CERN European Organization for Nuclear Research) · Published 21 June 2026 · DOI 10.5281/zenodo.20790800
In brief
“Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation” is a 2026 paper by Nitish Kumar*1, Jibin Mathew2, Dipanwita Pal3, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).
- Citations
- 0
- Authors
- 1
Abstract
Click chemistry, introduced by Sharpless and colleagues in 2001, has fundamentally transformed the way chemists and biologists construct molecules, probe biological systems, and develop therapeutics. Defined by its hallmark attributes—high yields, exquisite selectivity, mild reaction conditions, and compatibility with aqueous environments—click chemistry has evolved from an elegant synthetic concept into an indispensable technological platform. This comprehensive review systematically examines the mechanistic underpinnings and synthetic scope of the principal click reactions: copper(I) catalyzed azide alkyne cycloaddition (CuAAC), strain promoted azide alkyne cycloaddition (SPAAC), inverse electron demand Diels Alder (IEDDA) reactions involving tetrazines and strained alkenes, Staudinger ligation, oxime and hydrazone conjugation, and thiol ene additions. We critically evaluate their applications across the drug discovery pipeline—from fragment based screening and combinatorial library synthesis to activity based protein profiling (ABPP) and covalent drug design—and across the increasingly strategic arena of bioconjugation, encompassing antibody drug conjugates (ADCs), site specific protein modification, PEGylation, and radiolabelled imaging agents. Special attention is devoted to bioorthogonal click chemistry, which has enabled real time molecular imaging in living organisms and tissue selective prodrug activation. Emerging frontiers including sulfur(VI) fluoride exchange (SuFEx), photoclick chemistry, and click to release strategies are thoroughly discussed. We also address persistent challenges—copper cytotoxicity, pharmacokinetic liabilities of triazole containing drugs, and linker stability in ADCs—and outline translational pathways toward clinical implementation. Collectively, this review underscores click chemistry's transformative role in bridging synthetic chemistry and molecular medicine, and charts a future where precision bioconjugation enables next generation targeted therapies.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Pal3, N. K. J. M. D. (2026). Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20790800
MLA 9
Pal3, Nitish Kumar*1, Jibin Mathew2, Dipanwita. “Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.20790800.
Chicago
Pal3, Nitish Kumar*1, Jibin Mathew2, Dipanwita. 2026. “Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20790800.
Harvard
Pal3, N. K. J. M. D. (2026) ‘Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.20790800.
IEEE
N. K. J. M. D. Pal3, “Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.20790800.
BibTeX
@article{pal32026click,
title = {{Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation}},
author = {Pal3, Nitish Kumar*1, Jibin Mathew2, Dipanwita},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2026},
doi = {10.5281/zenodo.20790800},
url = {https://doi.org/10.5281/zenodo.20790800}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- click chemistry
- drug discovery
- bioconjugation
- copper-catalyzed azide-alkyne cycloaddition
- strain-promoted azide-alkyne cycloaddition
- inverse electron demand Diels-Alder reaction
- Staudinger ligation
- thiol-ene addition
Work with this paper
Most-cited papers in Chemistry
- CRC Handbook of Chemistry and PhysicsW.M. Haynes · CRC Press eBooks · 2014 · 58,210 citations
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Harry Towbin, Th. Staehelin, J Gordon · Proceedings of the National Academy of Sciences · 1979 · 53,242 citations
- Crystal structure refinement with SHELXLGeorge M. Sheldrick · Acta Crystallographica Section C Structural Chemistry · 2014 · 45,305 citations
- Comparison of simple potential functions for simulating liquid waterWilliam L. Jorgensen, Jayaraman Chandrasekhar, Jeffry D. Madura and 2 more · The Journal of Chemical Physics · 1983 · 41,735 citations
- Equation of State Calculations by Fast Computing MachinesN. Metropolis, Arianna W. Rosenbluth, M. N. Rosenbluth and 2 more · The Journal of Chemical Physics · 1953 · 38,111 citations
Questions about this paper
How do I cite this paper in APA style?
Pal3, N. K. J. M. D. (2026). Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20790800
How many times has this paper been cited?
0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Zenodo (CERN European Organization for Nuclear Research): sign in and open the full text from this page.
Who wrote this paper?
Nitish Kumar*1, Jibin Mathew2, Dipanwita Pal3.
What is the DOI of this paper?
10.5281/zenodo.20790800, permanently at https://doi.org/10.5281/zenodo.20790800. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.